BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Balagué O, Martínez A, Colomo L, Roselló E, Garcia A, Martínez-bernal M, Palacín A, Fu K, Weisenburger D, Colomer D, Burke JS, Warnke RA, Campo E. Epstein-Barr Virus Negative Clonal Plasma Cell Proliferations and Lymphomas in Peripheral T-cell Lymphomas: A Phenomenon With Distinctive Clinicopathologic Features. American Journal of Surgical Pathology 2007;31:1310-22. [DOI: 10.1097/pas.0b013e3180339f18] [Cited by in Crossref: 51] [Cited by in F6Publishing: 20] [Article Influence: 3.6] [Reference Citation Analysis]
Number Citing Articles
1 Willemsen M, Dielis AWJH, Samarska IV, Koster A, van Marion AM. A Rare Case of Angioimmunoblastic T-Cell Lymphoma with Epstein-Barr Virus-Negative Reed-Sternberg-Like B-Cells, Chylous Ascites, and Chylothorax. Case Rep Hematol 2017;2017:1279525. [PMID: 28487786 DOI: 10.1155/2017/1279525] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
2 Petković I, Stojnev S, Popović A, Krstić M, Pejčić I. EBV Negative Angioimmunoblastic T-Cell Lymphoma with Sequential Development of Diffuse Large B-Cell Lymphoma in Course of Progression. Indian J Hematol Blood Transfus 2021;37:694-6. [PMID: 34744354 DOI: 10.1007/s12288-021-01425-w] [Reference Citation Analysis]
3 Jaffe ES, Nicolae A, Pittaluga S. Peripheral T-cell and NK-cell lymphomas in the WHO classification: pearls and pitfalls. Mod Pathol 2013;26 Suppl 1:S71-87. [PMID: 23281437 DOI: 10.1038/modpathol.2012.181] [Cited by in Crossref: 74] [Cited by in F6Publishing: 59] [Article Influence: 9.3] [Reference Citation Analysis]
4 Raufi A, Jerkins J, Lyou Y, Jeyakumar D. A Patient with Supraclavicular Lymphadenopathy and Anterior Mediastinal Mass Presenting as a Rare Case of Composite Lymphoma: A Case Report and Literature Review. Case Rep Oncol 2016;9:854-60. [PMID: 28203178 DOI: 10.1159/000453255] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
5 Bajor-Dattilo EB, Pittaluga S, Jaffe ES. Pathobiology of T-cell and NK-cell lymphomas. Best Pract Res Clin Haematol 2013;26:75-87. [PMID: 23768642 DOI: 10.1016/j.beha.2013.04.007] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
6 Caballero A, Novelli S, Mozos A, Muret PG, Sierra J, Briones J. Silent T-cell receptor cutaneous T-cell lymphoma associated to a clonal plasma cell proliferation. Hematol Rep 2019;11:7841. [PMID: 30915203 DOI: 10.4081/hr.2019.7841] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Lynch RC, Gratzinger D, Advani RH. Clinical Impact of the 2016 Update to the WHO Lymphoma Classification. Curr Treat Options Oncol 2017;18:45. [PMID: 28670664 DOI: 10.1007/s11864-017-0483-z] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 8.0] [Reference Citation Analysis]
8 Egan C, Laurent C, Alejo JC, Pileri S, Campo E, Swerdlow SH, Piris M, Chan WC, Warnke R, Gascoyne RD, Xi L, Raffeld M, Pittaluga S, Jaffe ES. Expansion of PD1-positive T Cells in Nodal Marginal Zone Lymphoma: A Potential Diagnostic Pitfall. Am J Surg Pathol 2020;44:657-64. [PMID: 31764221 DOI: 10.1097/PAS.0000000000001414] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 7.0] [Reference Citation Analysis]
9 Swerdlow SH, Campo E, Pileri SA, Harris NL, Stein H, Siebert R, Advani R, Ghielmini M, Salles GA, Zelenetz AD, Jaffe ES. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016;127:2375-2390. [PMID: 26980727 DOI: 10.1182/blood-2016-01-643569] [Cited by in Crossref: 3329] [Cited by in F6Publishing: 3012] [Article Influence: 665.8] [Reference Citation Analysis]
10 Kaffenberger B, Haverkos B, Tyler K, Wong HK, Porcu P, Gru AA. Extranodal Marginal Zone Lymphoma-like Presentations of Angioimmunoblastic T-Cell Lymphoma: A T-Cell Lymphoma Masquerading as a B-Cell Lymphoproliferative Disorder. Am J Dermatopathol 2015;37:604-13. [PMID: 25839892 DOI: 10.1097/DAD.0000000000000266] [Cited by in Crossref: 11] [Article Influence: 2.2] [Reference Citation Analysis]
11 Nicolae A, Pittaluga S, Venkataraman G, Vijnovich-Baron A, Xi L, Raffeld M, Jaffe ES. Peripheral T-cell lymphomas of follicular T-helper cell derivation with Hodgkin/Reed-Sternberg cells of B-cell lineage: both EBV-positive and EBV-negative variants exist. Am J Surg Pathol 2013;37:816-26. [PMID: 23598959 DOI: 10.1097/PAS.0b013e3182785610] [Cited by in Crossref: 82] [Cited by in F6Publishing: 21] [Article Influence: 10.3] [Reference Citation Analysis]
12 Jang MA, Lee ST, Kim HJ, Kim S, Kim SH. Simultaneous occurrence of angioimmunoblastic T-cell lymphoma and plasma cell leukemia. Ann Lab Med 2015;35:149-51. [PMID: 25553298 DOI: 10.3343/alm.2015.35.1.149] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
13 Garcia-Herrera A, Song JY, Chuang SS, Villamor N, Colomo L, Pittaluga S, Alvaro T, Rozman M, de Anda Gonzalez J, Arrunategui AM, Fernandez E, Gonzalvo E, Estrach T, Colomer D, Raffeld M, Gaulard P, Campo E, Jaffe ES, Martinez A. Nonhepatosplenic γδ T-cell lymphomas represent a spectrum of aggressive cytotoxic T-cell lymphomas with a mainly extranodal presentation. Am J Surg Pathol 2011;35:1214-25. [PMID: 21753698 DOI: 10.1097/PAS.0b013e31822067d1] [Cited by in Crossref: 97] [Cited by in F6Publishing: 22] [Article Influence: 9.7] [Reference Citation Analysis]
14 Jiang M, Bennani NN, Feldman AL. Lymphoma classification update: T-cell lymphomas, Hodgkin lymphomas, and histiocytic/dendritic cell neoplasms. Expert Rev Hematol 2017;10:239-49. [PMID: 28133975 DOI: 10.1080/17474086.2017.1281122] [Cited by in Crossref: 44] [Cited by in F6Publishing: 39] [Article Influence: 11.0] [Reference Citation Analysis]
15 Kishimoto W, Takiuchi Y, Nakae Y, Tabata S, Fukunaga A, Matsuzaki N, Yuba Y, Kitano T, Arima N. A case of AITL complicated by EBV-positive B cell and monoclonal plasma cell proliferation and effectively treated with lenalidomide. Int J Hematol 2019;109:499-504. [PMID: 30604313 DOI: 10.1007/s12185-018-02587-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
16 Maruyama D, Tsukasaki K, Uchida T, Maeda Y, Shibayama H, Nagai H, Kurosawa M, Suehiro Y, Hatake K, Ando K, Yoshida I, Hidaka M, Murayama T, Okitsu Y, Tsukamoto N, Taniwaki M, Suzumiya J, Tamura K, Yamauchi T, Ueda R, Tobinai K. Multicenter phase 1/2 study of forodesine in patients with relapsed peripheral T cell lymphoma. Ann Hematol 2019;98:131-42. [PMID: 29974231 DOI: 10.1007/s00277-018-3418-2] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
17 Valera A, Balagué O, Colomo L, Martínez A, Delabie J, Taddesse-Heath L, Jaffe ES, Campo E. IG/MYC rearrangements are the main cytogenetic alteration in plasmablastic lymphomas. Am J Surg Pathol. 2010;34:1686-1694. [PMID: 20962620 DOI: 10.1097/pas.0b013e3181f3e29f] [Cited by in Crossref: 54] [Cited by in F6Publishing: 64] [Article Influence: 4.9] [Reference Citation Analysis]
18 Huppmann AR, Roullet MR, Raffeld M, Jaffe ES. Angioimmunoblastic T-cell lymphoma partially obscured by an Epstein-Barr virus-negative clonal plasma cell proliferation. J Clin Oncol 2013;31:e28-30. [PMID: 23213091 DOI: 10.1200/JCO.2012.43.3797] [Cited by in Crossref: 18] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
19 Xie Y, Jaffe ES. How I Diagnose Angioimmunoblastic T-Cell Lymphoma. Am J Clin Pathol 2021;156:1-14. [PMID: 34117736 DOI: 10.1093/ajcp/aqab090] [Reference Citation Analysis]
20 Willemze R, Cerroni L, Kempf W, Berti E, Facchetti F, Swerdlow SH, Jaffe ES. The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas. Blood 2019;133:1703-14. [PMID: 30635287 DOI: 10.1182/blood-2018-11-881268] [Cited by in Crossref: 298] [Cited by in F6Publishing: 247] [Article Influence: 149.0] [Reference Citation Analysis]